Severe COVID‐19 represents an undiagnosed primary immunodeficiency in a high proportion of infected individuals-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Severe COVID‐19 represents an undiagnosed primary immunodeficiency in a high proportion of infected individuals

Published:2022-01 Issue:4 Volume:11 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin & Trans Imm

Author:

Gray Paul E¹²,Bartlett Adam W¹²,Tangye Stuart G³⁴

Affiliation:

1. Department of Immunology and Infectious Diseases Sydney Children's Hospital Randwick NSW Australia

2. School of Women's and Children's Health University of New South Wales Randwick NSW Australia

3. Garvan Institute of Medical Research Darlinghurst NSW Australia

4. St Vincent's Clinical School UNSW Sydney Randwick NSW Australia

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1365

Reference103 articles.

1. COVID-19: consider cytokine storm syndromes and immunosuppression

2. Accelerated first-in-human clinical trial of EIDD-2801/MK-4482 (molnupiravir), a ribonucleoside analog with potent antiviral activity against SARS-CoV-2

3. A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia

4. Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

5. Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency Disorders;Clinical Immunology;2024-09

2. Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics;Scientific Reports;2024-06-20

3. A single-center experience of COVID-19 infection in patients with primary immunodeficiency;Journal of Allergy and Clinical Immunology: Global;2024-05

4. The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing;Seminars in Arthritis and Rheumatism;2024-04

5. Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics;2023-11-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3